Key facts about Ceftobiprole Medocaril
What dosages is Ceftobiprole Medocaril available in?
Ceftobiprole Medocaril is available as a 667 mg (equivalent to 500 mg of ceftobiprole) single-dose vial.
What is Ceftobiprole Medocaril used for?
Ceftobiprole Medocaril is a cephalosporin antibacterial indicated for the treatment of: Adult patients with Staphylococcus aureus bloodstream infections (bacteremia) (SAB), including those with right-sided infective endocarditis Adult patients with acute bacterial skin and skin structure infections (ABSSSI) Adult and pediatric patients (3 months to less than 18 years old) with community-acquired bacterial pneumonia (CABP)
How does Ceftobiprole Medocaril work?
Ceftobiprole Medocaril kills bacteria and works by preventing the formation of the bacterial cell wall.
How do I take Ceftobiprole Medocaril?
Ceftobiprole Medocaril is given as an IV infusion every 6 to 8 hours by a healthcare provider.
Is it safe for me to take Ceftobiprole Medocaril?
Ceftobiprole Medocaril is a safe and effective treatment when used for FDA approved indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. You should not take this medication if you have a severe hypersensitivity to Ceftobiprole Medocaril, or to other members of the cephalosporin class.
Ceftobiprole Medocaril Common Side Effects
Common side effects of Ceftobiprole Medocaril: Anemia Nausea Low potassium levels Vomiting Increased liver enzymes and bilirubin, Diarrhea, High blood pressure Leukopenia, Fever
Ceftobiprole Medocaril Serious Side Effects
Serious side effects are rare with Ceftobiprole Medocaril. Contact your healthcare provider immediately if you experience any of the following: Seizures and other adverse central nervous system (CNS) reactions Clostridioides difficile-associated diarrhea (CDAD)
Effects of other drugs, drug classes and over-the-counter products on Ceftobiprole Medocaril
The following medications may interact with Ceftobiprole Medocaril: Organic Anion Transporting Polypeptide 1B1/1B3 (OATP1B1/OATP1B3) Substrates: Ceftobiprole Medocaril may increase the plasma concentrations of OATP1B1 and OATP1B3 substrates. Concomitant administration is not recommended.
Who makes Ceftobiprole Medocaril?
Various FDA-approved generic manufacturers
Is Ceftobiprole Medocaril safe in pregnancy?
It is not known whether Ceftobiprole Medocaril will harm your unborn baby. Talk with your healthcare provider about the risks of taking this medication if you are pregnant or plan on becoming pregnant.
